IBD & Tea: what patients want to know when it comes to a clinical trial
Often, patients who live with Inflammatory Bowel Disease (IBD) do [...]
IBD & Tea: Building trust in new treatments & understanding clinical trials
Tina Aswani Omprakash is an award-winning blogger, speaker and patient [...]
Small drugs – Big considerations: How New Deal researchers are overcoming the challenges of scaling-up a potential IBD nanomedicine
A great chef could create an outstanding dish that revolutionizes [...]
From the lab to the market: regulations and development of new treatments.
Translating research ideas into prescription medicines is a long journey [...]
New Deal News: publications from IDIBAPS and Inserm
This summer has brought good news for the New Deal [...]
Tuning a drug: a glimpse into the process of formulation
In every drug, no matter whether it comes as a [...]
Successful review meeting in Brussels
In words of our project coordinator neither the storm nor [...]
January New Deal Reads
A new model of intestinal epithelial regeneration: could patients benefit? [...]
Safety first: towards a reliable treatment
From the spark of the therapeutic idea until the placement [...]
December New Deal Reads
Single-cell kinetics of siRNA-mediated mRNA degradation. Krzysztoń et al. 2019. Nanomedicine: Nanotechnology, Biology, and [...]
